Safety and Pharmacokinetic Evaluation of Nitrite for Prevention of Cerebral Vasospasm

Completed · Phase 2

Conditions studied: Subarachnoid Hemorrhage

In brief

The purpose of the study is to examine the safety of a 14 day infusion of sodium nitrite, and to study the pharmacokinetics of nitrite, during a 14 day infusion in patients with ruptured cerebral aneurysms.

Key facts

Study ID

NCT00873015

Run by

Hope Pharmaceuticals

People needed

19

Starts

2010-04-01

Expected to finish

2012-08-01

Last updated by the study team

2020-05-21

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ruptured cerebral aneurysm

You may not qualify if…

• Pregnancy, sickle cell disease, G6PD deficiency, anticoagulant therapy

Where it is running

• University of Virginia Health System Medical Center — Charlottesville, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.